RankAlpha logo
Back to Rankings

MYGN

Myriad GeneticsA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
MYGN vs peer average
90/100
MYGN vs. peer average (A vs. C)
Grade spread
A 1 · C 3 · D 2 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

AGMB is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $586.79M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerAGMBAgomAb Therapeutics
MYGN
Myriad Genetics
AGMB
AgomAb Therapeutics
Grade
A
A
Momentum
88
89
Value
41
47
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs AGMB

MYGN / AGMB
Grade Position
Above peers
MYGN vs. peer average (A vs. C)
90/100
Momentum
88
AGMB
Value
41
AGMB
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MYGN
1
AGMB
AgomAb Therapeutics NV ADR
A
100/100
Even
2
FDMT
4D Molecular Therapeutics Inc Common
F
20/100
+4
3
CTKB
Cytek Biosciences Inc Common
C
60/100
+2
4
PRME
Prime Medicine Inc Common
D
40/100
+3
5
NVCT
Nuvectis Pharma Inc Common
D
40/100
+3
AGMB is the first peer returned for this comparison set.